Reval appoints new director

- Daniel Andrews
- 28 Jan 2008

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Risk management software provider Reval has appointed Steve Rosenberg to its board of directors. Rosenberg is senior vice-president of Phase Forward, the data management provider for clinical trials and drug safety.

“Steve Rosenberg is a welcome addition to Reval’s board and we were fortunate to find someone with experience in hosting and supporting complex applications over the web,” says Jiro Okochi, Reval’s chief executive and co-founder.

Rosenberg has over 27 years’ experience in the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact info@risk.net to find out more.

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

You already have an account with us*. Sign in below to continue.